Can you provide the last earnings date for ARCADIA BIOSCIENCES INC?
ARCADIA BIOSCIENCES INC (RKDA) last reported earnings on 3/26/2026.
NASDAQ:RKDA • US0390143032
Past quarterly earnings results for ARCADIA BIOSCIENCES INC (RKDA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0.62 | -0.55 | 212.56% | 152.54% | 1.302M | 1.938M | -32.82% | -15.29% |
| Q2 2025 | 0.02 | -0.81 | 102.48% | -97.44% | 1.455M | 1.632M | -10.85% | 11.41% |
| Q1 2025 | 1.90 | -1.00 | 290.08% | 206.74% | 1.2M | 1.326M | -9.50% | -4.38% |
| Q4 2024 | -2.99 | -0.91 | -229.37% | -18.65% | 1.216M | 1.224M | -0.65% | 3.93% |
| Q3 2024 | -1.18 | -0.83 | -42.82% | 18.06% | 1.537M | 1.427M | 7.71% | -3.76% |
| Q2 2024 | 0.78 | 1.58 | -50.66% | 129.43% | 1.306M | 943.5K | 38.42% | -5.98% |
| Q1 2024 | -1.78 | -2.26 | 21.21% | 83.61% | 1.255M | 1.217M | 3.12% | -16.83% |
| Q4 2023 | -2.52 | -2.64 | 4.43% | 59.94% | 1.17M | 1.785M | -34.45% | 17.00% |
| Q3 2023 | -1.44 | -3.25 | 55.74% | 70.00% | 1.597M | 1.576M | 1.33% | 1.72% |
| Q2 2023 | -2.65 | -4.90 | 45.87% | 66.88% | 1.389M | 1.856M | -25.16% | -26.12% |
| Q1 2023 | -10.86 | -6.99 | -55.43% | -35.75% | 1.509M | 1.425M | 5.89% | -53.14% |
| Q4 2022 | -6.29 | -6.94 | 9.31% | 43.84% | 1M | 2.04M | -50.98% | -53.92% |
| Q3 2022 | -4.80 | -8.57 | 43.98% | -20.00% | 1.57M | 2.722M | -42.32% | -34.03% |
| Q2 2022 | -8.00 | -12.24 | 34.64% | 16.67% | 1.88M | 2.334M | -19.45% | 33.33% |
| Q1 2022 | -8.00 | -13.87 | 42.33% | -266.67% | 3.22M | 1.937M | 66.24% | 287.95% |
| Q4 2021 | -11.20 | -12.24 | 8.50% | -131.82% | 2.17M | 3.399M | -36.16% | -69.57% |
| Q3 2021 | -4.00 | -12.04 | 66.77% | 83.33% | 2.38M | 2.559M | -6.99% | 667.74% |
| Q2 2021 | -9.60 | -11.15 | 13.92% | 76.70% | 1.41M | 1.74M | -18.97% | 403.57% |
| Q1 2021 | 4.80 | -14.01 | 134.27% | -58.62% | 830K | 751.403K | 10.46% | 167.74% |
| Q4 2020 | 35.20 | -16.73 | 310.43% | - | 7.13M | 1.281M | 456.60% | - |
| Q3 2020 | -24.00 | -22.17 | -8.26% | - | 310K | 1.165M | -73.39% | - |
| Q2 2020 | -41.20 | -23.94 | -72.12% | - | 280K | 1.893M | -85.21% | - |
| Q1 2020 | 11.60 | -22.24 | 152.17% | - | 310K | 816K | -62.01% | - |
Notes
ARCADIA BIOSCIENCES INC (RKDA) last reported earnings on 3/26/2026.
ARCADIA BIOSCIENCES INC (RKDA) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, ARCADIA BIOSCIENCES INC (RKDA) has beaten EPS estimates in 3 out of 4 releases.